Effects of ceftolozane/tazobactam in patients with hematologic malignanncy and pseudomonas aeruginosa infections
Latest Information Update: 06 Jan 2019
At a glance
- Drugs Ceftolozane/tazobactam (Primary)
- Indications Pseudomonal infections
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 06 Jan 2019 New trial record
- 10 Dec 2018 Results published in the Antimicrobial Agents and Chemotherapy